Vellanki Avanish
Insider CIK 1856682 · RAIN President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 304,485 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 266,500 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 14,115 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 152,150 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 133,250 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 31,832 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 30,150 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-26 | 2024-01-26 | 2,550,910 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 133,250 | — | $0 | 133,250 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 266,500 | — | $0 | 266,500 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 318,600 | — | $0 | 318,600 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-06-01 | 2022-06-02 | 25,000 | $2.29 | $57.3K | 2,471,627 | SEC↗ |
| RAIN Rain Therapeutics Inc. | G Gift | 2022-04-14 | 2022-04-15 | 59,618 | — | $0 | 2,446,627 | SEC↗ |
| RAIN Rain Therapeutics Inc. | G Gift | 2022-04-14 | 2022-04-15 | 59,618 | — | $0 | 79,283 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise deriv | 2022-03-11 | 2022-03-15 | 14,468 | — | $0 | 31,832 | SEC↗ |
| RAIN Rain Therapeutics Inc. | M Exercise | 2022-03-11 | 2022-03-15 | 14,468 | $4.00 | $57.9K | 2,837,009 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-02-02 | 2022-02-04 | 182,300 | — | $0 | 182,300 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 12,108 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 11,212 | — | $0 | 2,372,541 | SEC↗ |